Abeona Therapeutics (ABEO) PT Lowered to $17 at Stifel on Zevaskyn sales estimates
Tweet Send to a Friend
Stifel analyst Stephen Willey lowered the price target on Abeona Therapeutics (NASDAQ: ABEO) to $17.00 (from $19.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
